TACT2
Trial to Assess Chelation Therapy 

Once again, the Schachter Center will be a participating site in the Trial to Assess Chelation Therapy. This will be Chelation Therapy's second trial, conducted to confirm the results of the first trial which took place some years ago, which positively showed the ability of Chelation Therapy to prevent and treat aspects of heart disease.

The following are links to information about this trial:

Official Handout 

Press Release

The TACT2 Trial Website

For further information about the TACT2 trial at our Center, please call 845-368-4700 to speak to Sally Minniefield, RN, PA-C or Gabrielle Clenin.

 

 

 
 

Important Note: You are encouraged to seek the advice of a competent medical professional
before making any decisions that could affect your health. See our disclaimer.

2016 Michael B. Schachter, M.D., P.C. 
Reproduction of the content of this website is strictly prohibited.